West Pharmaceutical Services 

$250.64
349
+$5.5+2.24% Tuesday 20:00

統計

當日最高
252.24
當日最低
245.92
52週高點
322.34
52週低點
187.43
成交量
571,365
平均成交量
1,001,081
市值
18.05B
本益比
41.85
股息殖利率
0.35%
股息
0.88

即將到來

股息

0.35%股息殖利率
Feb 26
$0.22
Nov 25
$0.22
Aug 25
$0.21
May 25
$0.21
Feb 25
$0.21
10年成長
6.03%
5年成長
4.98%
3年成長
4.55%
1年成長
3.53%

財報

23Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
1.23
1.5
1.77
2.04
預期EPS
1.679061
實際EPS
不適用

財務

16.06%利潤率
有盈利
2020
2021
2022
2023
2024
2025
6.15B營收
987.4M淨利

分析師評級

$320.83平均目標價
最高預估為 355.00。
來自過去6個月內的 6 則評分。這不是投資建議。
買入
67%
持有
33%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 WST 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Show more...
執行長
Mr. Eric M. Green
員工
10600
國家
US
ISIN
US9553061055

上市

0 Comments

分享你的想法

FAQ

West Pharmaceutical Services 今天的股價是多少?
WST 目前價格為 $250.64 USD,過去 24 小時上漲了 +2.24%。在圖表上更密切關注 West Pharmaceutical Services 股價表現。
West Pharmaceutical Services 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,West Pharmaceutical Services 的股票以代號 WST 進行交易。
West Pharmaceutical Services 的股價在上漲嗎?
WST 股票較上週上漲 +1.47%,本月下跌 -1.45%,過去一年 West Pharmaceutical Services 上漲 +13.84%。
West Pharmaceutical Services 的市值是多少?
今天 West Pharmaceutical Services 的市值為 18.05B
West Pharmaceutical Services 下一次財報日期是什麼時候?
West Pharmaceutical Services 將於 April 23, 2026 公布下一次財報。
West Pharmaceutical Services 上一季度的財報如何?
WST 上一季度的財報為每股 2.04 USD,預估為 1.83 USD,帶來 +11.32% 的驚喜。下一季度的預估財報為每股 不適用 USD。
West Pharmaceutical Services 去年的營收是多少?
West Pharmaceutical Services 去年的營收為 6.15BUSD。
West Pharmaceutical Services 去年的淨利是多少?
WST 去年的淨收益為 987.4MUSD。
West Pharmaceutical Services 會發放股息嗎?
是的,WST 的股息每 每季 發放一次。每股最新股息為 0.22 USD。截至今日,股息殖利率(FWD)% 為 0.35%。
West Pharmaceutical Services 有多少名員工?
截至 April 01, 2026,公司共有 10,600 名員工。
West Pharmaceutical Services 位於哪個產業?
West Pharmaceutical Services從事於Health Care產業。
West Pharmaceutical Services 何時完成拆股?
West Pharmaceutical Services 上次拆股發生於 September 27, 2013,比例為 2:1。
West Pharmaceutical Services 的總部在哪裡?
West Pharmaceutical Services 的總部位於 US 的 Exton。